Redirect Notice

Looks like you clickedhttp://www.eigerbio.com/eiger-biopharmaceuticals-announces-phase-2-ultra-results-of-ubenimex-in-lower-leg-lymphedema-study-did-not-meet-primary-or-secondary-endpoint/

If you do not want to visit that page, you can close this browser tab.